Skip to main content
. 2019 Aug;8(4):1242–1248. doi: 10.21037/tcr.2019.07.10

Figure 1.

Figure 1

Expression level of FR+CTC. The dot plot of FR+CTC levels in (A) lung cancer patients, benign lung disease patients, and healthy controls; and (B) stage I lung cancer patients, benign lung disease patients, and healthy controls. Lines indicate the median and inter-quartile range of FR+CTC level. *** indicates P<0.0001. FR+CTC, folate receptor-positive circulating tumor cell.